aTyr Pharma Q1 2026 Earnings NarrowerThanExpected Loss Provides Some Relief Amid Pipeline Development Forte Biosciences Q1 2026 Earnings Prerevenue Biotech Misses EPS Estimates Stock Dips on Narrower Loss Miss Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress BOOM Q1 2026 Earnings Surprising EPS Beat Despite Challenging Environment Manchester United Q1 2026 Earnings Strong EPS Surprise Amid Revenue Disparities CETY Q4 2024 Earnings Net Loss of 002 Per Share as Clean Energy Firm Navigates Growth Phase